Rothschild & Co Asset Management US’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-442,769	Closed	-$7.27M	–	367
2019 Q4	$7.27M	Sell	442,769 -20,139	-4%	-$304K	0.08%	270
2019 Q3	$6.15M	Sell	462,908 -4,304	-0.9%	-$60K	0.07%	275
2019 Q2	$6.58M	Buy	467,212 +45,071	+11%	+$717K	0.07%	276
2019 Q1	$7.77M	Sell	422,141 -43,413	-9%	-$989K	0.08%	269
2018 Q4	$12.2M	Buy	465,554 +23,738	+5%	+$558K	0.15%	227
2018 Q3	$10.1M	Sell	441,816 -8,205	-2%	-$168K	0.1%	267
2018 Q2	$8.57M	Sell	450,021 -902,555	-67%	-$15.1M	0.09%	276
2018 Q1	$22.8M	Sell	1,352,576 -19,515	-1%	-$327K	0.25%	166
2017 Q4	$20.9M	Buy	1,372,091 +59,757	+5%	+$887K	0.22%	185
2017 Q3	$23.5M	Buy	+1,312,334	New	+$22M	0.26%	167